Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Every Cure logo — Every Cure is leveraging AI to unlock the full potential of...

Every Cure

Every Cure is leveraging AI to unlock the full potential of every drug to treat every disease it possibly can.

Founded 2022 United States Philadelphia, United States 38 employees Grant Total: $48.30M Biotechnology

General Information

Company Name Every Cure
Founded Year 2022
Location United States Philadelphia, United States
Employees 38
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Every Cure. To contact Every Cure, visit everycure.org.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Every Cure compare?

A PDF of Every Cure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Every Cure soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Every Cure

Every Cure is a biotechnology startup, leveraging AI to unlock the full potential of every drug to treat every disease possible. The nonprofit organization is dedicated to repurposing existing drugs, which is considered the fastest and most efficient way to treat diseases with the greatest return on investment for saving lives. The company is taking a revolutionary and disruptive approach by developing a comprehensive, open-source data engine, aiming to generate predictive efficacy scores for all 3,000 drugs against all 12,000 diseases. This innovative approach aims to overcome systemic barriers by identifying and advancing promising repurposing opportunities to save lives. At the founded in 2022, Every Cure received a significant grant investment of $48.30M from the Advanced Research Projects Agency for Health on 28 February 2024. Every Cure is collaborating with academia, industry, and government to integrate proprietary and public data into a comprehensive dataset while optimizing AI ranking algorithms. Furthermore, the company is focused on validating the most promising drug-disease matches, performing trials, and ensuring patient access to effective therapies. In summary, Every Cure's disruptive approach and innovative use of AI in the biotechnology space, combined with its successful grant investment, position it as a promising entity with the potential to revolutionize the field of drug repurposing and disease treatment.

Business keywords: drug development, drug repurposing, non-profit, medicine, medtech

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $48.30M 1
Advanced Research Projects Agency for Health
28 Feb 2024

Every Cure Alternatives & Competitors

View All Alternatives
Every Cure vs
Lantern Pharma Inc. (Nasdaq: LTRN)
Lantern Pharma Inc. (Nasdaq: LTRN) United States

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

Post-IPO Secondary
28 employees
AI, Biopharma
Every Cure vs
DrugBank
DrugBank Canada

Trusted intelligence OS connecting biomedical and commercial insight for next-generation drug discov...

Seed
61 employees
Biotechnology, Pharmaceutical
Every Cure vs
Pepscope
Pepscope The Netherlands

Kinome Activity Profiling

Venture round
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About Every Cure

Every Cure is leveraging AI to unlock the full potential of every drug to treat every disease it possibly can.
Every Cure was founded in 2022.
Every Cure is headquartered in Philadelphia, United States.
Every Cure operates in Biotechnology. Its work centres on drug development, drug repurposing, non-profit and medicine.
Every Cure has approximately 38 employees.
Every Cure has completed 1 funding round, raising a total of $48.30M. The latest funding stage is Grant.
Top alternatives and competitors to Every Cure include Lantern Pharma Inc. (Nasdaq: LTRN), DrugBank, Pepscope, Melior Discovery, Kejako. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Every Cure and Lantern Pharma Inc. (Nasdaq: LTRN) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Every Cure, https://bouncewatch.com/company/every-cure, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes